[HTML][HTML] Aldosterone synthase inhibitors and dietary interventions: a combined novel approach for prevention and treatment of cardiovascular disease

A Awosika, A Khan, U Adabanya, AE Omole, RM Millis - Cureus, 2023 - ncbi.nlm.nih.gov
Systemic hypertension (HTN) is the hallmark of cardiovascular disease and the forerunner of
heart failure. These associations have been established over decades of research on …

Vasopressin as possible treatment option in autism spectrum disorder

K László, D Vörös, P Correia, CL Fazekas, B Török… - Biomedicines, 2023 - mdpi.com
Autism spectrum disorder (ASD) is rather common, presenting with prevalent early problems
in social communication and accompanied by repetitive behavior. As vasopressin was …

Anti-angiogenic mechanisms and serotonergic dysfunction in the Rgs2 knockout model for the study of psycho-obstetric risk

SB Gumusoglu, MD Kiel, A Gugel… - …, 2024 - nature.com
Psychiatric and obstetric diseases are growing threats to public health and share high rates
of co-morbidity. G protein-coupled receptor signaling (eg, vasopressin, serotonin) may be a …

[HTML][HTML] Neuromodulation of Cardiac Ischemic Pain: Role of the Autonomic Nervous System and Vasopressin

E Szczepanska-Sadowska - Journal of Integrative Neuroscience, 2024 - imrpress.com
Cardiac pain is an index of cardiac ischemia that helps the detection of cardiac hypoxia and
adjustment of activity in the sufferer. Drivers and thresholds of cardiac pain markedly differ in …

Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure

NS Dhalla, KO Mota, V Elimban, AK Shah… - Cells, 2024 - mdpi.com
Heart failure is the common concluding pathway for a majority of cardiovascular diseases
and is associated with cardiac dysfunction. Since heart failure is invariably preceded by …

Interplay of Angiotensin Peptides, Vasopressin, and Insulin in the Heart: Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus

E Szczepanska-Sadowska - International Journal of Molecular Sciences, 2024 - mdpi.com
The present review draws attention to the specific role of angiotensin peptides [angiotensin II
(Ang II), angiotensin-(1-7)(Ang-(1-7)], vasopressin (AVP), and insulin in the regulation of the …

Metabolic effects of vasopressin in pathophysiology of diabetic kidney disease

S Lebedeva, A Margaryan, E Smolyarchuk… - Frontiers in …, 2023 - frontiersin.org
The diabetic kidney disease (DKD) is the major cause of the chronic kidney disease (CKD).
Enhanced plasma vasopressin (VP) levels have been associated with the pathophysiology …

Data-driven derivation of an adverse outcome pathway linking vascular endothelial growth factor receptor (VEGFR), endocrine disruption, and atherosclerosis

D Ehrlich, S Krishna, N Kleinstreuer - ALTEX-Alternatives to animal …, 2024 - altex.org
Abstract Dysregulation of Vascular Endothelial Growth Factor (VEGF) and its receptor
(VEGFR) contributes to atherosclerosis and cardiovascular disease (CVD), making it a …

Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis

M Maciejewska, A Stec, M Zaremba… - Clinical, Cosmetic …, 2023 - Taylor & Francis
Background Systemic sclerosis is a connective tissue disease characterized by
vasculopathy and progressive fibrosis, leading to multiorgan dysfunction. Given the complex …

THE MANAGEMENT STRATEGIES IN THE PLACENTA ACCRETA SPECTRUM IN TERTIARY CENTERS IN TÜRKİYE

S Büyükkurt, R Melekoğlu, İ Hatipoğlu - Journal of Istanbul Faculty of …, 2024 - dergipark.org.tr
Objective: To determine the differences and consensus points in managing patients with
placenta accreta spectrum (PAS) disorder in a nationwide survey. Material and Method …